Analytical Performance of the Axis-Shield Afinion® for Hemoglobin A1c Measurement: Impact of Lot Number

Clinical Laboratory

Volumn 60, Issue 3, 2014, Pages 369-376

  Dupuy, Anne Marie ^a   Badiou, Stéphanie ^a   Elong Bertard, Cécile ^a   Bargnoux, Anne Sophie ^a   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A; HEMOGLOBIN A1C; HEMOGLOBIN F; HEMOGLOBIN S;

ADULT; ARTICLE; CALIBRATION; CONSULTATION; CORRELATION ANALYSIS; CORRELATIONAL STUDY; DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HEMATOLOGY ANALYZER; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; REPRODUCIBILITY;

CHILD; CHROMATOGRAPHY, LIQUID; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIMIT OF DETECTION; POINT-OF-CARE SYSTEMS;

EID: 84896449108     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130209     Document Type: Article

References (19)

1. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010;56(1):44-52.
2. Little RR, Lenters-Westra E, Rohlfing CL, Slingerland R. Point-of-care assays for hemoglobin A(1c): is performance adequate? Clin Chem 2011 Sep;57(9):1333-4.
3. Wood JR, Kaminski BM, Kollman C, et al. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device. J Diabetes Sci Technol 2012 Mar 1;6(2):380-6.
4. Executive Summary: Standards of Medical Care in Diabetes - 2010. American Diabetes Association. Diabetes Care 2010;33:S4-S10.
5. Sacks DB, Arnold M, Bakris GL, et al. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:793-8.
6. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31(18):1473-8.
7. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:13.
8. NGSP News (updated 03/10) (http://www.ngsp.org/).
9. Guggenmoos-Holzmann I. The meaning of kappa: probabilistic concepts of reliability and validity revisited. J Clin Epidemiol 1996;49:775-82. (Pubitemid 26280729)
10. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996;33 (Pt. 1):1.
11. th 2006. http://afssaps.fr/2006.pdf.
12. Petersen JR, Omoruyi FO, Mohammad AA, Shea TJ, Okorodudu AO, Ju H. Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method. Clin Chim Acta 2010;411(23-24):2062-6.
13. Little RR. Analysis of the accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device. J Diabetes Sci Technol 2012 Mar 1;6(2):387-8.
14. Sánchez-Mora C, S Rodríguez-Oliva M, Fernández- Riejos P, et al. Evaluation of two HbA1c point-of-care analyzers. Clin Chem Lab Med 2011;49(4):653-7.
15. Diem P, Wälchli M, Mullis PE, Marti U. Agreement between HbA1c measured by DCA 2000 and by HPLC: effects of fetal hemoglobin concentrations. Arch Med Res 2004;35(2):145-9. (Pubitemid 38316834)
16. Rohlfing CL, Connolly SM, England JD, et al. The Effect of Elevated Fetal Hemoglobin on Hemoglobin A1c Results. Five Common Hemoglobin A1c Methods Compared With the IFCC Reference Method. Am J Clin Pathol 2008;129(5):811-4.
17. John WG, Braconnier F, Miedema K, Aulesa C, Piras G. Evaluation of the Menarini-Arkray HA 8140 hemoglobin A1c analyzer. Clin Chem 1997;43(6 Pt 1):968-75. (Pubitemid 27246987)
18. Little RR, Rohlfing CL, Hanson S, Connolly S, Higgins T, Weykamp CW, D'Costa M, Luzzi V, Owen WE, Roberts WL. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem. 2008 Aug;54(8):1277-82.
19. Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009 May 1;3(3):446-51.